Evidence map›Paper›PMID 25246399›Full record

ArticleAntimicrobial agents and chemotherapy2014

First description of OXA-48 carbapenemase harbored by Escherichia coli and Enterobacter cloacae from a single patient in Portugal.

Vera Manageiro, Eugénia Ferreira, Margarida Pinto, Manuela Caniça

Open access · bronzeAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Vera ManageiroNational Reference Laboratory of Antibiotic Resistances and Health-Associated Infections, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal Center for the Study of Animal Science, CECA/ICETA, University of Oporto, Oporto, Portugal.
Eugénia FerreiraNational Reference Laboratory of Antibiotic Resistances and Health-Associated Infections, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal.
Margarida PintoLaboratory of Microbiology, Centro Hospitalar de Lisboa Central, EPE, Lisbon, Portugal.
Manuela CaniçaNational Reference Laboratory of Antibiotic Resistances and Health-Associated Infections, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal manuela.canica@insa.min-saude.pt.
National Institute of Health Dr. Ricardo Jorge · PTCentro Hospitalar de Lisboa Central · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAnti-Bacterial AgentsBacterial ProteinsBacteriuriaBase Sequencebeta-LactamasesConjugation, GeneticDrug Resistance, Multiple, BacterialEnterobacter cloacaeEnterobacteriaceae InfectionsEscherichia coliEscherichia coli InfectionsFemaleGene ExpressionHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase OXA-48, Enterobacter cloacaebeta-Lactamases

Identifiers

PMID25246399
PMCPMC4249543
OpenAlexW2070301492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.